The American Bar Association (ABA) will be offering a teleseminar entitled "Patent Law in Light of Mayo v. Prometheus: Claims to Laws of Nature Are Not Patentable" on April 24, 2012 from 1:00 - 2:30 pm (EDT). James R. Myers, Ching-Lee Fukuda, and Jane T. Gunnison of Ropes & Gray LLP will examine the Mayo v. Prometheus opinion and will clarify patent eligibility as a subject matter under Section 101 of the Patent Act.
The registration fee for the webcast is $169 (for either the telephone seminar or audio webcast options). Those interested in registering for the teleseminar, can do so here, by calling 800-CLE-NEWS (800-253-6397), or by faxing an order form to 215-243-1664.
Contributors
Juristat #4 Overall Rank
Contact the Docs
Foreign Correspondents
Docs on Twitter
Recent Posts
- AbbVie Files Amicus Brief in Amgen v. Sanofi
- GlaxoSmithKline Files Amicus Brief in Amgen v. Sanofi
- Webinar on Priority Entitlement in Europe
- Webinar on Obtaining and Managing REMS Patent
- Patent Law Academics File Amicus Brief in Amgen v. Sanofi
- Amgen Files Reply Brief in Amgen v. Sanofi
- Conference & CLE Calendar
- Webinar on Prep, Prosecution & Profitability
- PIUG Webinar on Searching IP5 Literature
- Webinar on Unified Patent Court
Disclaimer
- "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat #8 Overall Rank
- Powered By Invesp
« Webinar on Patent Prosecution under the AIA | Main | Webinar on Prometheus in the Post-Bilski Age »
April 06, 2012
The comments to this entry are closed.
March 2023
Categories
- Best Mode (2)
- Biosimilars (242)
- Biotech/Pharma Business (175)
- Biotech/Pharma News (274)
- Board of Patent Appeals and Interferences (12)
- Claim Construction (97)
- Conferences & CLE's (2944)
- Court Report (507)
- Damages (37)
- Definiteness (25)
- District Court (214)
- Double Patenting (30)
- Enablement (40)
- Federal Circuit (965)
- Food and Drug Administration (102)
- Hatch-Waxman (88)
- Inequitable Conduct (52)
- Infringement - Contributory or Induced (25)
- Infringement - Literal or DOE (88)
- Injunction (33)
- International IP (294)
- Inventorship (15)
- Licensing (129)
- Media Commentary (68)
- Miscellaneous (160)
- News from Abroad (102)
- Novelty (70)
- Obviousness (213)
- Patent Exhaustion (3)
- Patent Legislation (305)
- Patent Litigation (216)
- Patent Office Rules & Procedures (813)
- Patent Profiles (104)
- Patent Prosecution (98)
- Patent Prosecution - International (26)
- Patent Research (4)
- Patent Trial and Appeal Board (357)
- Patentable Subject Matter (633)
- Personalized Medicine (5)
- Post-Grant Proceedings (155)
- PTAB Report (9)
- Study/Report (6)
- Supreme Court (245)
- Tools (5)
- Trade Secrets (10)
- Utility (4)
- Venue (11)
- Written Description (84)
Patent Resources
Patent Search
- Patent Search
Patent Blogs & Sites
- 717 Madison Place
- America-Israel Patent Law
- Anticipate This!
- BlawgIT
- Chicago IP Litigation Blog
- FedCircuitBlog
- Global Patent Quality
- Innovation Alliance
- Intellectual Property Watch
- IP Dragon
- IPcopy
- McCabe Ali LLP
- IPWatchdog.com
- Life Science IP
- Orange Book Blog
- Patent Blurb
- Patently-O
- Patentology
- Patents4Life
- Reexamination Center
- Intellepedia – IP News Center
- SPICY IP
Comments